STIC Investments Venture is a private equity general partner firm with offices in China, Hong Kong, South Korea, Taiwan, United States and Vietnam.
STIC has made a partial exit from Korean biotech business Access Bio and is expecting an overall 4x return on its $2.2 investment.
STIC Investments and Hana Daetoo Securities' consortium will acquire a 49% stake in LIG Nex1.
IMM, Actium and STIC, as well as an European defence company, presented bids for a 49% stake in LIG Nex1.
Read more news concerning STIC Investments Venture
A sampling of STIC Investments Venture portfolio companies:
View all of the investments in their portfolio
This firm also pursues other investment strategies:
Registration is fast, free and easy
Already a member?